InsiderTrades.com logo

IRD Insider Trading

Insider Ownership Percentage: 11.70%
Insider Buying (Last 12 Months): $323,890.00
Insider Selling (Last 12 Months): $16,377,278.31

Opus Genetics Insider Trading History Chart

This chart shows the insider buying and selling history at Opus Genetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Opus Genetics Share Price & Price History

Current Price: $4.20
Price Change: ▲ Price Increase of +0.21 (5.26%)
As of 06/3/2026 04:00 PM ET

This chart shows the closing price history over time for IRD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Opus Genetics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2026Fighting Blindness FoundationDirectorSell1,700,000$4.35$7,395,000.003,792,171View SEC Filing Icon  
4/23/2026Ashwath JayagopalInsiderSell7,542$5.19$39,142.98509,233View SEC Filing Icon  
4/23/2026Benjamin R YerxaPresidentSell7,470$5.24$39,142.80711,535View SEC Filing Icon  
4/23/2026George MagrathCEOSell9,511$5.22$49,647.421,741,344View SEC Filing Icon  
4/23/2026Joseph K SchachleCOOSell4,697$5.22$24,518.34296,084View SEC Filing Icon  
4/23/2026Rabourn Amy ZarembaInsiderSell1,641$5.20$8,533.20188,671View SEC Filing Icon  
4/23/2026Robert E GagnonCFOSell7,842$5.18$40,621.56592,158View SEC Filing Icon  
3/16/2026Ashwath JayagopalInsiderSell3,719$5.12$19,041.28516,775View SEC Filing Icon  
3/16/2026George MagrathCEOSell24,438$5.21$127,321.981,750,855View SEC Filing Icon  
3/16/2026Joseph K SchachleCOOSell3,719$5.25$19,524.75300,781View SEC Filing Icon  
3/16/2026Rabourn Amy ZarembaInsiderSell2,816$5.25$14,784.00190,312View SEC Filing Icon  
12/29/2025Cam GallagherDirectorBuy81,000$1.98$160,380.001,891,430View SEC Filing Icon  
12/29/2025Cam GallagherDirectorBuy83,000$1.97$163,510.0083,000View SEC Filing Icon  
12/9/2025Fighting Blindness FoundationDirectorSell4,000,000$2.15$8,600,000.005,492,171View SEC Filing Icon  
12/26/2024George MagrathCEOBuy100,000$0.98$98,000.00599,150View SEC Filing Icon  
11/18/2024George MagrathCEOBuy9,706$1.02$9,900.12492,950View SEC Filing Icon  
11/15/2024George MagrathCEOBuy90,294$1.01$91,196.94483,244View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Opus Genetics (NASDAQ:IRD)

14.97% of Opus Genetics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IRD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Opus Genetics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/29/2026Perceptive Advisors LLC1,835,842$8.35M0.2%-57.6%2.255%Search for SEC Filing on Google Icon
5/19/2026Bank of America Corp DE67,015$0.31M0.0%+2,965.6%0.082%Search for SEC Filing on Google Icon
5/18/2026ADAR1 Capital Management LLC1,849,004$8.41M0.5%+4,522.5%2.272%Search for SEC Filing on Google Icon
5/15/2026OMERS ADMINISTRATION Corp41,600$0.19M0.0%-52.7%0.051%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC73,209$0.33M0.0%-42.0%0.090%Search for SEC Filing on Google Icon
5/5/2026Regency Capital Management Inc. DE68,000$0.31M0.1%+47.8%0.095%Search for SEC Filing on Google Icon
4/20/2026Kestra Private Wealth Services LLC12,800$58K0.0%-20.0%0.018%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC16,810$34K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd23,737$48K0.0%-54.1%0.034%Search for SEC Filing on Google Icon
2/18/2026Occudo Quantitative Strategies LP12,205$25K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/18/2026Opaleye Management Inc.1,120,000$2.25M0.3%+1.8%1.624%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC2,002,550$4.03M0.0%N/A2.904%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.2,718,029$5.46M0.0%N/A3.941%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC40,000$80K0.0%N/A0.058%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.1,104,996$2.22M0.0%+15.7%1.602%Search for SEC Filing on Google Icon
2/17/2026Blair William & Co. IL27,466$55K0.0%+12.3%0.040%Search for SEC Filing on Google Icon
2/16/2026OMERS ADMINISTRATION Corp87,900$0.18M0.0%N/A0.127%Search for SEC Filing on Google Icon
2/13/2026Nantahala Capital Management LLC4,781,330$9.61M0.3%+42.9%6.933%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP157,648$0.32M0.0%N/A0.229%Search for SEC Filing on Google Icon
2/13/2026Johnson Investment Counsel Inc.20,000$40K0.0%N/A0.029%Search for SEC Filing on Google Icon
2/13/2026Mink Brook Asset Management LLC1,665,631$3.35M2.1%+34.5%2.415%Search for SEC Filing on Google Icon
2/13/2026State Street Corp173,253$0.35M0.0%+18.8%0.251%Search for SEC Filing on Google Icon
2/13/2026Voss Capital LP441,891$0.89M0.0%-21.4%0.641%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN241,871$0.49M0.0%+6,290.3%0.351%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC126,309$0.25M0.0%-27.3%0.183%Search for SEC Filing on Google Icon
2/11/2026Regency Capital Management Inc. DE46,000$92K0.0%N/A0.067%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC504,983$1.02M0.0%+7.7%0.732%Search for SEC Filing on Google Icon
2/9/2026Texas Capital Bank Wealth Management Services Inc78,000$0.16M0.0%N/A0.113%Search for SEC Filing on Google Icon
11/20/2025Voss Capital LP562,377$0.93M0.0%+3.9%0.815%Search for SEC Filing on Google Icon
11/17/2025Mink Brook Asset Management LLC1,237,947$2.04M1.4%+3.4%1.904%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC113,416$0.19M0.0%+496.9%0.174%Search for SEC Filing on Google Icon
11/14/2025Creative Planning128,366$0.21M0.0%N/A0.197%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.22,508$37K0.0%+95.6%0.035%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP108,338$0.18M0.0%+169.6%0.167%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.1,342,025$2.21M0.0%+35.3%2.240%Search for SEC Filing on Google Icon
8/15/2025Opaleye Management Inc.1,220,000$1.15M0.2%+3.8%2.045%Search for SEC Filing on Google Icon
8/15/2025Mink Brook Asset Management LLC1,197,616$1.13M1.0%+47.8%2.007%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC42,065$40K0.0%-63.9%0.071%Search for SEC Filing on Google Icon
8/14/2025Nantahala Capital Management LLC3,345,923$3.15M0.1%+6.0%5.608%Search for SEC Filing on Google Icon
8/14/2025Voss Capital LP541,159$0.51M0.0%+260.8%0.907%Search for SEC Filing on Google Icon
8/12/2025BIOS Capital Management LP3,683,429$3.46M4.8%+270.1%6.174%Search for SEC Filing on Google Icon
5/16/2025AWM Investment Company Inc.524,245$0.52M0.1%N/A1.153%Search for SEC Filing on Google Icon
5/15/2025Nantahala Capital Management LLC3,157,895$3.10M0.1%N/A6.943%Search for SEC Filing on Google Icon
5/15/2025Royal Bank of Canada304,123$0.30M0.0%N/A0.669%Search for SEC Filing on Google Icon
5/14/2025BIOS Capital Management LP995,249$0.98M1.2%N/A2.188%Search for SEC Filing on Google Icon
5/14/2025Comerica Bank30,000$29K0.0%N/A0.066%Search for SEC Filing on Google Icon
5/14/2025Mink Brook Asset Management LLC810,080$0.80M0.8%N/A1.781%Search for SEC Filing on Google Icon
5/14/2025Voss Capital LP150,000$0.15M0.0%N/A0.330%Search for SEC Filing on Google Icon
5/12/2025Virtu Financial LLC26,275$26K0.0%N/A0.058%Search for SEC Filing on Google Icon
5/5/2025Kestra Private Wealth Services LLC48,341$47K0.0%N/A0.106%Search for SEC Filing on Google Icon
5/2/2025Apollon Wealth Management LLC28,089$28K0.0%N/A0.062%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Opus Genetics logo
Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.
Read More on Opus Genetics

Today's Range

Now: $4.20
Low: $3.96
High: $4.24

50 Day Range

MA: $4.86
Low: $4.09
High: $5.75

52 Week Range

Now: $4.20
Low: $0.90
High: $5.81

Volume

915,930 shs

Average Volume

908,049 shs

Market Capitalization

$341.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Who are the company insiders with the largest holdings of Opus Genetics?

Opus Genetics' top insider shareholders include:
  1. Fighting Blindness Foundation (Director)
  2. Cam Gallagher (Director)
  3. George Magrath (CEO)
  4. Benjamin R Yerxa (President)
  5. Robert E Gagnon (CFO)
  6. Ashwath Jayagopal (Insider)
  7. Joseph K Schachle (COO)
  8. Rabourn Amy Zaremba (Insider)
Learn More about top insider investors at Opus Genetics.

Who are the major institutional investors of Opus Genetics?

Opus Genetics' top institutional shareholders include:
  1. ADAR1 Capital Management LLC — 2.27%
  2. Perceptive Advisors LLC — 2.26%
  3. Renaissance Technologies LLC — 0.09%
  4. Regency Capital Management Inc. DE — 0.10%
  5. Bank of America Corp DE — 0.08%
  6. OMERS ADMINISTRATION Corp — 0.05%
Learn More about top institutional investors of Opus Genetics stock.

Which institutional investors are selling Opus Genetics stock?

Within the last quarter, IRD stock was sold by these institutional investors:
  1. Perceptive Advisors LLC
  2. Renaissance Technologies LLC
  3. OMERS ADMINISTRATION Corp
  4. Kestra Private Wealth Services LLC
In the previous year, company insiders that have sold Opus Genetics company stock include:
  1. Fighting Blindness Foundation (Director)
  2. George Magrath (CEO)
  3. Benjamin R Yerxa (President)
  4. Robert E Gagnon (CFO)
  5. Ashwath Jayagopal (Insider)
  6. Joseph K Schachle (COO)
  7. Rabourn Amy Zaremba (Insider)
Learn More investors selling Opus Genetics stock.

Which institutional investors are buying Opus Genetics stock?

Within the last quarter, IRD stock was acquired by institutional investors including:
  1. ADAR1 Capital Management LLC
  2. Bank of America Corp DE
  3. Regency Capital Management Inc. DE
In the previous year, these company insiders have bought Opus Genetics stock:
  1. Cam Gallagher (Director)
  2. George Magrath (CEO)
Learn More investors buying Opus Genetics stock.

Opus Genetics Active Insiders

George Magrath
George Magrath (Age 41)
CEO
2 recent trades
Benjamin R Yerxa
Benjamin R Yerxa
President
1 recent trades
Joseph K Schachle
Joseph K Schachle (Age 61)
COO
2 recent trades
Robert E Gagnon
Robert E Gagnon
CFO
1 recent trades
Cam Gallagher
Cam Gallagher
Director
2 recent trades
Ashwath Jayagopal
Ashwath Jayagopal
Insider
2 recent trades
Rabourn Amy Zaremba
Insider
2 recent trades